Westchester Capital Management (New York)’s Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri STEM.WS Stock Holding History

Westchester Capital Management (New York)’s Portfolio STEM.WS Stock Details STEM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-83,500	Closed	-$1.98M	–	416
2021 Q2	$1.98M	Buy	+83,500	New	+$1.24M	0.05%	160

Westchester Capital Management (New York)'s STEM.WS Position: Q3 2021 in Review

Westchester Capital Management (New York) sold out of Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri (STEM.WS) in Q3 2021, closing a stake of 83,500 shares — an estimated $1.98M sold.

Westchester Capital Management (New York) first reported a position in STEM.WS in Q2 2021 and held it in 1 quarter. The position peaked at $1.98M in Q2 2021. 0 funds tracked by Wall St. Rank hold STEM.WS as of Q3 2021.

Westchester Capital Management (New York) reported no remaining Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri position as of Q3 2021 after selling out during the quarter.
Westchester Capital Management (New York) sold 83,500 Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri shares in Q3 2021, an estimated $1.98M.
Westchester Capital Management (New York) first reported a position in Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri in Q2 2021 and held it in 1 quarter.
Westchester Capital Management (New York)'s Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri position peaked at $1.98M in Q2 2021.
0 funds tracked by Wall St. Rank held Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri as of Q3 2021.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.